John Rothka sells 3,800 CNR shares; 1,000 RSUs listed (CNR)
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
John Rothka reported insider sales of Common Stock for CNR. The filing shows a sale of $348,150 for 3,800 shares on 03/10/2026. The filing also lists 1,000 Common Shares tied to Restricted Stock Units dated 02/23/2026 under equity compensation.
Positive
- None.
Negative
- None.
Insights
Insider reported a routine restricted-share sale and lists RSUs.
The filing records a 3,800-share sale by John Rothka on 03/10/2026 for $348,150, a transaction size disclosed verbatim. It also lists 1,000 Common Shares linked to Restricted Stock Units dated 02/23/2026.
These items are routine compensation-related disclosures. Cash‑flow treatment and any planned resale mechanics are not detailed in the excerpt; subsequent filings would show method and timing if required.
FAQ
What did the CNR filing disclose about insider John Rothka?
The filing discloses a sale of 3,800 shares of Common Stock by John Rothka on 03/10/2026 for $348,150. It also lists 1,000 shares tied to Restricted Stock Units dated 02/23/2026.
Does the filing state proceeds recipient or use of proceeds for the sale?
The excerpt reports the sale amount of $348,150 but does not specify who received the proceeds or how they will be used. The filing text provides the sale amount and date without further cash‑flow details.
What do the listed Restricted Stock Units in the CNR filing indicate?
The filing lists 1,000 Common Shares associated with Restricted Stock Units dated 02/23/2026 under equity compensation. The entry identifies the award date and share count but does not state whether a resale has occurred.
Which broker is shown on the filing for these transactions?
The filing lists Stifel Nicolaus & Company Inc at 501 N Broadway, St. Louis, MO in connection with the securities information. No additional broker activity details are included in the excerpt.